Eudaimonia Partners’s Mastercard MA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
$681K Buy
1,414
+35
+3% +$16K 0.16% 136
2023
Q4
$588K Sell
1,379
-307
-18% -$123K 0.15% 136
2023
Q3
$668K Buy
1,686
+37
+2% +$14.9K 0.16% 141
2023
Q2
$648K Sell
1,649
-47
-3% -$17.6K 0.15% 153
2023
Q1
$616K Sell
1,696
-119
-7% -$43.2K 0.15% 153
2022
Q4
$631K Sell
1,815
-51
-3% -$16.8K 0.15% 151
2022
Q3
$531K Sell
1,866
-360
-16% -$119K 0.14% 159
2022
Q2
$702K Buy
2,226
+138
+7% +$47.5K 0.13% 176
2022
Q1
$746K Buy
+2,088
New +$751K 0.13% 189
2021
Q3
$826K Buy
2,376
+100
+4% +$36.4K 0.15% 167
2021
Q2
$831K Buy
2,276
+503
+28% +$187K 0.16% 158
2021
Q1
$631K Sell
1,773
-317
-15% -$111K 0.13% 172
2020
Q4
$746K Buy
2,090
+113
+6% +$37.6K 0.17% 142
2020
Q3
$668K Buy
1,977
+108
+6% +$35.1K 0.17% 137
2020
Q2
$553K Sell
1,869
-739
-28% -$208K 0.21% 114
2020
Q1
$630K Buy
2,608
+1,109
+74% +$330K 0.28% 95
2019
Q4
$447K Buy
+1,499
New +$423K 0.18% 136

Other funds holding MA

Eudaimonia Partners's MA Position: Q1 2024 in Review

Eudaimonia Partners increased its Mastercard (MA) stake by 2.5% in Q1 2024, buying an estimated $16K and bringing the position to 1,414 shares worth $681K. The position accounts for 0.16% of the portfolio, ranked #136.

Eudaimonia Partners first reported a position in MA in Q4 2019 and has held it in 17 quarters since. The position peaked at $831K in Q2 2021. 3,113 funds tracked by Wall St. Rank hold MA as of Q1 2024.

  • Eudaimonia Partners held 1,414 shares of Mastercard worth $681K as of Q1 2024.
  • Eudaimonia Partners bought 35 Mastercard shares in Q1 2024, an estimated $16K.
  • Mastercard made up 0.16% of Eudaimonia Partners's portfolio in Q1 2024, its #136 holding.
  • Eudaimonia Partners first reported a position in Mastercard in Q4 2019 and has held it in 17 quarters since.
  • Eudaimonia Partners's Mastercard position peaked at $831K in Q2 2021.
  • 3,113 funds tracked by Wall St. Rank held Mastercard as of Q1 2024.

Based on Eudaimonia Partners's 13F filing for Q1 2024, filed 25 Apr 2024.